Press

Sydney, Australia and Marcq-en-Baroeul, France – June 12, 2025: MicroBioGen, an Australian-based leader in yeast biotechnology, is pleased to announce a groundbreaking, worldwide exclusive license and collaboration agreement with Lesaffre, a key global player in the field of microorganisms and…

On 28 May 2025, in the presence of Emmanuel Macron, President of the French Republic, and Prabowo Subianto, President of the Republic of Indonesia, Lesaffre and its long-standing partner Citra Bonang signed an investment agreement in Jakarta, Indonesia. This agreement…

Lesaffre, an independent French key global player in fermentation and microorganisms, and Zilor, a privately held Brazilian multinational that produces sugar, ethanol, renewable electric energy, and natural ingredients for animal nutrition from sugarcane processing, announce today the completion of the…

Lesaffre, a key global player in the field of fermentation and microorganisms, announces the acquisition of Altar, a French start-up specializing in Adaptive Laboratory Evolution (ALE). Created in 2017, Altar will complement Lesaffre’s existing know-how and technologies to boost the…

Lesaffre, an independent key global player in fermentation and microorganisms, announced today the acquisition of a majority stake in Biorigin, a business unit of Zilor, a multinational company producing yeast derivative products, to enhance the supply of yeast derivatives for…

Lesaffre, an independent key global player in fermentation and microorganisms, announces today the closing of a transaction with dsm-firmenich, a leading innovator in nutrition, health, and beauty, regarding its yeast extract business. Through this acquisition, Lesaffre solidifies its commitment to…